Most Download

Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month| Most Downloaded in Recent Year|

Most Downloaded in Recent Month
Please wait a minute...
For Selected: Toggle Thumbnails

Clinical and pathological characteristics of lymphoproliferative diseases after liver transplantation in children——A single center retrospective analysis 

Zhai Lili, Wang Zhenglu, Yin Zhiqi, Zhang Fubo, Cao Kaiyue, Hu Zhandong, Wang Jingwen, Cai Wenjuan.
2023, 11 (5): 417-423. DOI: 10.3969/j.issn.2095-5332.2023.05.006
Abstract207)      PDF (1321KB)(22)      

Objective To analyze the clinical and pathological characteristics ofpost-transplantlymphoproliferative disorder (PTLD) in children after liver transplantation, and to provide reference for diagnosis and treatment. Methods The clinical and pathological data of PTLD patients after liver transplantation were collected from May 2020 to May 2022 in the Pediatric Liver Transplantation Department of Tianjin First Central Hospital. The gender, age, surgical method, postoperative immunosuppression regimen, PTLD treatment regimen, prognosis, clinical manifestations,liver function, plasma EBV-DNA, and imaging examination results were included. Pathological classification and immunohistochemical staining results were analyzed according to WHO classification of lymphoid tissue tumors in 2016. The clinical, pathological and prognostic features of the patients were analyzed retrospectively. Results There were 8 patients with pathologically diagnosed PTLD after liver transplantation, including 4 males and 4 females, aged 1 ~ 4 years. All the 8 patients had biliary atresia as the primary disease and underwent living donor liver transplantation (LDLT). In this group,5 cases had lymph node enlargement,5 cases had digestive system symptoms (including abdominal pain,intestinal obstruction, ascites, and abdominal distension),4 cases had liver dysfunction,3 cases had fever, and 1 case had abnormal liver and kidney function. The mean plasma EBV-DNA was 46072copies/ml. The non-destructive, pleomorphic and monomorphic cases accounted for 12.5% (1/8),25% (2/8) and 62.5% (5/8), respectively. Burkitt lymphoma, diffuselarge B-cell lymphoma and mature T-cell lymphoma accounted for 60% (3/5),20% (1/5) and 20% (1/8) of monomorphic PTLD, respectively. After diagnosis, tacrolimus was tapered or discontinued. Six patients received chemotherapy and2 patients received hemodialysis. Two cases of local space occupying operation was performed. Of the 8 patients,7 caseshad remission and 1 died. Conclusion The early diagnosis of PTLD and the selection of reasonable treatment planaccording to pathological classification can improve the prognosis of patients. Children receiving chemotherapy should be alert to tumolysis syndrome and be given active and effective intervention in time. 

2022, 10 (3): 255-258. DOI: 10.3969/j.issn.2095-5332.2022.03.014
Abstract135)      PDF (814KB)(64)      
Comparison the efficacy and safety of long-acting or intermediate-acting insulin combined with oral hypoglycemic agents in the reatment of hyperglycemia in the early stage of kidney transplantation
NING Yuan, LI Ning, WU Xiao-tong.
2013, 1 (4): 226-228.
Abstract178)      PDF (1589KB)(124)      

Objective To evaluate efficacy and safety of long-acting or intermediate-acting insulin combined with oral hypoglycemic drug in treatment of patients with high blood sugar early after kidney transplantation. Methods 45 cases at 1 month after kidney transplantation with high blood glucose were divided into three groups according to insulin used,insulin detemir group(A),insulin glargine group(B)and Novolin N group(C),and 15 patients in each group. The original oral acarbose dose was maintained,and each group of patients received 1 dose a day injections of insulin for 4 weeks. Blood glucose and incidence of hypoglycemia were monitored. Results Fasting blood glucose and post prandial blood sugar after treatment of three groups were significantly decreased,with most

significantly decreased in the A group ;and A,B groups decreased more than C group〔fasting blood glucose (mmol/L):3.08±0.51,2.86±0.58 vs. 0.92±0.34 ;post prandial blood sugar(mmol/L):4.38±1.19,4.18±1.22 vs. 2.34±0.77〕,the difference was statistically significant(all P0.05);A,B groups of hypoglycemia events were obviously less than group C(6%,13% vs. 26%). Conclusions In patients early after kidney transplantation with high blood glucose and cannot be controlled well by acarbose,treatment with addition of long-acting or intermediate- acting insulin can decrease the level of blood glucose obviously. Insulin detemir is effective and gentle for control forblood glucose with less incidence of hypoglycemia,which is a more ideal physiological simulated insulin secretion.

Therapeutic effect of parental liver transplantation and domino-assisted liver transplantation on childrenwith metabolic liver disease
Dong Chong, Gao Wei, Ma Nan, Sun Chao, Zhang Wei, Meng Xingchu, Qin Hong, Wu Bing, Shen Zhongyang.
2018, 6 (6): 464-466. DOI: 10.3969/j.issn.2095-5332.2018.06.013
Abstract175)      PDF (1954KB)(97)      
Objective To investigate the effect of living donor liver transplantation plus domino auxiliary liver transplantation in the treatment of metabolic liver disease in children. Methods The first patient with ornithine aminotransferase deficiency(OTCD)received living donor liver transplantation(left lateral liver)and the patient's right lobe was procured for domino auxiliary donor liver transplantation. At the same time,the recipient of domino auxiliary liver transplantation was type Ⅰ crigler-najjar syndrome. The right half of the liver with the middle hepatic vein was resected,The domino liver was retained for vascular and biliary reconstruction. Results Recipie nt who received living donor liver transplantation had normal and sustained liver function and normal blood ammonia, the patient who received domino auxiliary liver transplantation had normal bilirubin and blood ammonia,Abdominal CT examination followed up one year after the transplantation was normal. Conclusion Non-sclerosing metabolic liver diseases can be treated by liver transplantation, and their livers can be used as domino donor livers,this type of liver graft can be successfully applied to auxiliary liver transplantation of different metabolic liver diseases,thus it provids new ideas for patients with metabolic liver diseases to expand the source of donor livers.
2022, 10 (4): 301-308. DOI: 10.3969/j.issn.2095-5332.2022.04.003
Abstract373)      PDF (741KB)(1029)      
2020, 8 (5): 337-341. DOI: 10.3969/j.issn.2095-5332.2020.05.003
Abstract171)      PDF (2013KB)(262)      
2024, 12 (6): 554-556. DOI: 10.3969/j.issn.2095-5332.2024.06.015
Abstract65)      PDF (1422KB)(7)      
2018, 6 (2): 132-135. DOI: 10.3969/j.issn.2095-5332.2018.02.012
Abstract89)      PDF (1701KB)(30)      
2016, 4 (1): 54-56.
Abstract64)      PDF (2274KB)(225)      
2022, 10 (2): 146-146. DOI: 10.3969/j.issn.2095-5332.2022.02.010
Abstract384)      PDF (684KB)(635)      
Protective effect of normothermic machine perfusion preservation device for splitting in porcine livers
2017, 5 (3): 197-205.
Abstract108)      PDF (5378KB)(28)      

Objective We used the principle of extracorporeal membrane oxygenation(ECMO)to assembleour own normothermic machine perfusion(NMP)system,and to verify the effect and stability of NMP in the split liver process of perfusion and preservation of Bama miniature pig. Methods Four healthy Bama miniature pig were selected,the liver was quickly harvested and was connected to the NMP device for preservation and perfusion. In the process of split,portal vein,hepatic artery flow and pressure,the temperature of liver preservation were recorded. Results During the liver splitting procedure, the portal vein pressure was maintained between 8.75- 9.75 mmHg(1 mmHg = 0.133 kPa). Meanwhile, the hepatic artery pressure was maintained in a range of 92.00- 92.75 mmHg. In the splitting process, portal venous flow reduced from(455.00±107.55)mmHg before splitting to (392.50±125.27)mmHg after splitting, while hepatic artery flow reduced from(180.75±59.46)mmHg before splitting to(126.25±6.99)mmHg after splitting. Before splitting, the pH value(7.24±0.10)was lower than the baseline value(7.50±0.08), and it gradually increased with splitting and reached a value of(7.60±0.13)after splitting, which was slightly higher than the baseline value. The PO2 was maintained in a range of 482.25-521.00 mmHg during splitting, which was significantly higher than the baseline value(304.00±78.11)mmHg. HCO3 - was(10.10± 5.04)mmol/L before splitting,which was significantly lower than the baseline value of(24.05±0.31)mmol/L, while it gradually increased. Na + was maintained in a range of 142.75-149.25mmol/L during splitting. During the preservation splitting,K+ gradually increased from(3.45±0.33)mmol/L at baseline to(4.98±1.12)mmol/L at the end of splitting. Before splitting, the lactic acid was(2.86±1.77)mmol/L, which was lower than the baseline value of (3.85±2.58)mmol/L,and it gradually increased to(6.00±3.73)mmol/L at the end of splitting. The bile secretion was gradually reduced with splitting before splitting :(16.75±3.30)ml/h, during splitting :(10.55±1.83)ml/h,and after splitting :(6.53±1.33)ml/h. At the beginning of perfusion preservation,the alanine aminotransferase(ALT), lactate dehydrogenase(LDH),and alkaline phosphatase(ALP)were lower than the baseline level. ALT and LDH gradually increased with splitting,whereas ALP was maintained in a lower level in the splitting. At the beginning of perfusion preservation, aspartate aminotransferase(AST)was comparable with the baseline value,and it was gradually increased with splitting. The cell structure in the liver did not show significant changes after splitting with NMP preservation compared with that before the preservation. Conclusion Our NMP system in the process of liver splitting is relatively stable,with a certain clinical value.

2022, 10 (4): 361-363. DOI: 10.3969/j.issn.2095-5332.2022.04.014
Abstract141)      PDF (1221KB)(133)      
2022, 10 (4): 295-300. DOI: 10.3969/j.issn.2095-5332.2022.04.002
Abstract107)      PDF (924KB)(99)      
2022, 10 (3): 269-273. DOI: 10.3969/j.issn.2095-5332.2022.03.017
Abstract111)      PDF (819KB)(120)      
2018, 6 (5): 385-. DOI: 10.3969/j.issn.2095-5332.2018.05.010
Abstract215)      PDF (947KB)(246)      
2019, 7 (1): 62-. DOI: 10.3969/j.issn.2095-5332.2019.01.016
Abstract84)      PDF (583KB)(57)      
2017, 5 (3): 172-176. DOI: 10.3969/j.issn.2095-5332.2017.03.002
Abstract97)      PDF (3038KB)(87)      
2021, 9 (1): 6-9. DOI: 10.3969/j.issn.2095-5332.2021.01.002
Abstract106)      PDF (758KB)(82)      
2025, 13 (3): 243-247. DOI: 10.3969/j.issn.2095-5332.2025.03.012
Abstract105)      PDF (777KB)(9)      
Application of magnetic-assisted rapid vascular reconstruction in liver transplantation
Zhang Xiaogang, Liu Xuemin, Zhang Xufeng, Li Yu, Wang Shanpei, Shi Aihua, Lu Qiang, Wang Rongfeng, Wang Bo, Song Jiashu, Lv Yi
2020, 8 (6): 440-445. DOI: 10.3969/j.issn.2095-5332.2020.06.007
Abstract204)      PDF (4119KB)(86)      
Objective To explore the application of magnetic-assisted fast major vascular reconstruction technique in liver transplantation. Methods The clinical data of liver transplant patients undergoing magneticassisted fast major vascular reconstruction and conventional suture reconstruction between November 2018 and December 2019 were retrospectively analyzed. Results A total of five patients were finally enrolled in magneticassisted Liver transplantation(LT), whereas 172 patients underwent regular LT. The donor age, primary disease,as well as the warm and cold ischemia time were comparable between magnetic-assisted and regular LT groups (P > 0.05). In addition, the recipient age, sex, primary disease and preoperative Child-Pugh classification were not different, patients undergoing magnetic-assisted LT experienced an median anhepatic period of 10.3( 9.5~13.2)min, which was significantly shorter versus 43.5( 35.8~ 55.6) min of patients who underwent regular LT (P < 0.001). Of note, postoperative liver transaminase, as well as total bilirubin level were not significantly different at different time stages( P> 0.05). In addition, the incidence of vascular associated complications, such as hepatic artery, portal vein or IVC thrombosis, biliary stenosis, as well as acute renal dysfunction were all comparable between the two groups( P> 0.05). Conclusion Fast revascularization of the donor liver by using the novel magnetics is safe and feasible in LT.